FiercePharma
03/30/2012
 FiercePharma| 03.30.12 | Pfizer faces class action suit; AstraZeneca getspatent win for Seroquel XR |
03/29/2012
 FiercePharma| 03.29.12 | Who's next to move on Amylin?; Judge chides FDA inAstraZeneca case |
03/29/2012
 FiercePharmaCraig Lipset Invites You to DIA 2012 Annual Meeting |
03/28/2012
 FiercePharma| 03.28.12 | Pfizer open to Abbott-style split, analyst says; Judgeslams FDA for importing execution drugs |
03/27/2012
 FiercePharma| 03.27.12 | Hard-to-get ISTA wins $500M Bausch & Lomb bid; Is IPsafe in India? |
03/26/2012
 FiercePharma| 03.26.12 | AZ loses bid to block Seroquel copies; Sample shelvesbare as pharma overhauls sales |
03/23/2012
 FiercePharma| 03.23.12 | FDA seeks advice on making more drugs OTC; EMA OKsByetta for expanded use |
03/15/2012
 FiercePharma| 03.15.12 | J&J's Weldon due for $143M retirement package; GSKdelays Alli sale |
03/14/2012
 FiercePharmaYour PDUFA Whitepaper download |
03/12/2012
 FiercePharma| 03.12.12 | U.S. wants more than $1B in J&J Risperdal settlement |
03/09/2012
 FiercePharma| 03.09.12 | New Zytiga use could double sales potential; Seroquelpetition denied, AZ needs M&A |
03/08/2012
 FiercePharma| 03.08.12 | Health plans sue Big Pharma over co-pay coupons;Bayer, Novartis circle Pfizer unit |
03/07/2012
 FiercePharma| 03.07.12 | Gilenya market share drops after FDA review; Sanofi'sViehbacher talks emerging markets |
03/06/2012
 FiercePharma| 03.06.12 | Misbehaving drugmakers could lose patent rights; Morereps sue Novo for back overtime |
03/05/2012
 FiercePharma| 03.05.12 | GSK to add hundreds of reps in China; How vexing isthe statin-diabetes link? |
03/05/2012
 FiercePharmaShorten the long and winding road to conducting Alzheimer's Diseaseclinical trials |
03/02/2012
 FiercePharma| 03.02.12 | Europe takes steps to speed drug pricing, paymentrulings; Nestle leads pack pursuing Pfizer unit |
02/22/2012
 FiercePharma| 02.22.12 | J&J picks Gorsky over McCoy for CEO seat; Teva wrapspropofol suits for $285M |
02/22/2012
 FiercePharmaHow to optimize clinical trial performance? Webinar offers answers! |
02/21/2012
 FiercePharma| 02.21.12 | Pfizer reportedly weighs animal health IPO; Quebecplant fixes force Sandoz to slash output |
02/21/2012
 FiercePharmaClinical Trial Market Trends Initiate Supplier Response |
02/17/2012
 FiercePharma| 02.17.12 | AZ peddles discounted cancer drug directly toconsumers; J&J yanks another Tylenol product |
02/16/2012
 FiercePharma| 02.16.12 | Sanofi yanks drug batch; Fake Avastin may not be theonly injectable counterfeit |
02/15/2012
 FiercePharma| 02.15.12 | FDA, Roche probe bogus Avastin; Merck gains tractionin Brazil |
02/14/2012
 FiercePharma| 02.14.12 | Pharma is heartburn HQ as 44% fear job loss; Obamabudget digs into drugmakers' wallets |
02/13/2012
 FiercePharma| 02.13.12 | Ben Venue's idled plant triggers 'dire' shortage;Valeant nabs eye-drug company |
02/13/2012
 FiercePharmaCovering the Medical Product Life Cycle from Molecule to Market |
02/10/2012
 FiercePharma| 02.10.12 | Overtime controversy for sales reps spreads |
Notice: We utilize cookies and other web technologies on our site. For more information regarding our use of web technologies, please review our Privacy Policy.
